Virion Therapeutics, LLC

Biotechnology company · Newark, Delaware, United States

Virion Therapeutics, LLC is a biotechnology company headquartered in Newark, Delaware, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $5.7 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Virion Therapeutics at a glance

Typebiotechnology company

HeadquartersNewark, Delaware, United States

Earliest incorporation on record2018

SEC CIK1746726

What does Virion Therapeutics do?

Private fundraising reported to the SEC

25 Form D notices; the most recent reported $5.7 million sold (2021).

Frequently asked questions about Virion Therapeutics

Where is Virion Therapeutics headquartered?

Virion Therapeutics, LLC is headquartered in Newark, Delaware, United States.

What does Virion Therapeutics do?

Virion Therapeutics, LLC is a biotechnology company.

When was Virion Therapeutics founded?

The earliest incorporation on record for Virion Therapeutics, LLC is in 2018, according to public company registers.

Similar companies

Toivoa, IncNewark, Delaware, United States
Cell Podium LLCNewark, New Jersey, United States
Simphotek, Inc.Newark, New Jersey, United States
Fauna Bio IncorporatedNewark, California, United States
Kaneka Americas Holding IncNewark, California, United States
Koi Biotherapeutics Inc.Newark, Delaware, United States
Nangiotx IncNewark, New Jersey, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences